Literature DB >> 21252195

Remote monitoring of implantable-cardioverter defibrillators: results from the Reliability of IEGM Online Interpretation (RIONI) study.

Christian Perings1, Wolfgang Rudolf Bauer, Hans-Jürgen Bondke, Christian Mewis, Michael James, Dirk Böcker, Paul Broadhurst, Thomas Korte, Egon Toft, Florian Hintringer, Jacques Clémenty, Jörg Otto Schwab.   

Abstract

AIMS: Intracardiac electrograms (IEGMs) recorded by implantable cardioverter-defibrillators (ICDs) are essential for arrhythmia diagnosis and ICD therapy assessment. Short IEGM snapshots showing 3-10 s before arrhythmia detection were added to the Biotronik Home Monitoring system in 2005 as the first-generation IEGM Online. The RIONI study tested the primary hypothesis that experts' ratings regarding the appropriateness of ICD therapy based on IEGM Online and on standard 30 s IEGM differ in <10% of arrhythmia events. METHODS AND
RESULTS: A total of 619 ICD patients were enrolled and followed for 1 year. According to a predefined procedure, 210 events recorded by the ICDs were selected for evaluation. Three expert board members rated the appropriateness of ICD therapy and classified the underlying arrhythmia using coded IEGM Online and standard IEGM to avoid bias. The average duration of IEGM Online was 4.4±1.5 s. According to standard IEGM, the underlying arrhythmia was ventricular in 135 episodes (64.3%), supraventricular in 53 episodes (25.2%), oversensing in 17 episodes (8.1%), and uncertain in 5 episodes (2.4%). The expert board's rating diverged between determinable IEGM Online tracings and standard IEGM in 4.6% of episodes regarding the appropriateness of ICD therapy (95% CI up to 8.0%) and in 6.6% of episodes regarding arrhythmia classification (95% CI up to 10.5%).
CONCLUSION: By enabling accurate evaluation of the appropriateness of ICD therapy and the underlying arrhythmia, the first-generation IEGM Online provided a clinically effective basis for timely interventions and for optimized patient management schemes, which was comparable with current IEGM recordings.

Entities:  

Mesh:

Year:  2011        PMID: 21252195     DOI: 10.1093/europace/euq447

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  6 in total

1.  Home monitoring of implantable cardioverter-defibrillators: interpretation reliability of the second-generation "IEGM Online" system.

Authors:  Herbert Nägele; Jolana Lipoldová; Hanno Oswald; Gunnar Klein; Arif Elvan; Ernst Vester; Wolfgang Bauer; Hansjürgen Bondke; Sebastian Reif; Claudia Daub; Frank Menzel; Jürgen Schrader; Göran Zach
Journal:  Europace       Date:  2015-01-06       Impact factor: 5.214

2.  Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems.

Authors:  Niraj Varma; Behzad B Pavri; Bruce Stambler; Justin Michalski
Journal:  Europace       Date:  2012-12-19       Impact factor: 5.214

Review 3.  Interactive telemedicine: effects on professional practice and health care outcomes.

Authors:  Gerd Flodgren; Antoine Rachas; Andrew J Farmer; Marco Inzitari; Sasha Shepperd
Journal:  Cochrane Database Syst Rev       Date:  2015-09-07

Review 4.  Telemedicine and cardiac implants: what is the benefit?

Authors:  Niraj Varma; Renato Pietro Ricci
Journal:  Eur Heart J       Date:  2012-12-04       Impact factor: 29.983

5.  Feasibility and efficacy of a remote real-time wireless ECG monitoring and stimulation system for management of ventricular arrhythmia in rabbits with myocardial infarction.

Authors:  Zhi-Wen Zhou; Kai Gou; Zhang-Yuan Luo; Wei Li; Wen-Zan Zhang; Yi-Gang Li
Journal:  Exp Ther Med       Date:  2014-04-25       Impact factor: 2.447

6.  Active periodic electrograms in remote monitoring of pacemaker recipients: the PREMS study.

Authors:  Arnaud Lazarus; Benoit Guy-Moyat; Pierre Mondoly; Frédéric Pons; Carlo Quaglia; Jean-Philippe Elkaim; Sandrine Bayle; Frédéric Victor
Journal:  Europace       Date:  2019-01-01       Impact factor: 5.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.